Free Trial

Veeva Systems (VEEV) Stock Forecast & Price Target

Veeva Systems logo
$282.03 +5.57 (+2.01%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$284.98 +2.95 (+1.04%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Veeva Systems - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
2
Hold
8
Buy
14

Based on 24 Wall Street analysts who have issued ratings for Veeva Systems in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 24 analysts, 2 have given a sell rating, 8 have given a hold rating, and 14 have given a buy rating for VEEV.

Consensus Price Target

$274.17
-2.79% Downside
According to the 24 analysts' twelve-month price targets for Veeva Systems, the average price target is $274.17. The highest price target for VEEV is $329.00, while the lowest price target for VEEV is $192.00. The average price target represents a forecasted downside of -2.79% from the current price of $282.03.
Get the Latest News and Ratings for VEEV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Veeva Systems and its competitors.

Sign Up

VEEV Analyst Ratings Over Time

TypeCurrent Forecast
7/21/24 to 7/21/25
1 Month Ago
6/21/24 to 6/21/25
3 Months Ago
4/22/24 to 4/22/25
1 Year Ago
7/22/23 to 7/21/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
14 Buy rating(s)
15 Buy rating(s)
15 Buy rating(s)
15 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
8 Hold rating(s)
6 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$274.17$269.80$256.32$228.27
Forecasted Upside-2.79% Downside-3.39% Downside18.75% Upside24.57% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

VEEV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

VEEV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Veeva Systems Stock vs. The Competition

TypeVeeva SystemsMedical CompaniesS&P 500
Consensus Rating Score
2.50
2.82
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside-2.79% Downside8,725.28% Upside11.45% Upside
News Sentiment Rating
Positive News

See Recent VEEV News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/14/2025KeyCorp
3 of 5 stars
Aleksey Yefremov
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$285.00 ➝ $325.00+17.83%
6/2/2025Mizuho
3 of 5 stars
S. Valiquette
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$280.00 ➝ $295.00+5.34%
5/30/2025Citigroup
3 of 5 stars
Tyler Radke
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$265.00 ➝ $329.00+18.28%
5/29/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Stan Berenshteyn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$285.00 ➝ $300.00+6.69%
5/29/2025Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brian Peterson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$285.00 ➝ $310.00+12.25%
5/29/2025Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Joe Meares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetHold ➝ Hold$217.00 ➝ $230.00-16.72%
5/29/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Karl Keirstead
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$250.00 ➝ $285.00+3.20%
5/29/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Grossman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$272.00 ➝ $295.00+6.82%
5/29/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brent Bracelin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$255.00 ➝ $325.00+17.68%
5/29/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Craig Hettenbach
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetUnderweight ➝ Underweight$201.00 ➝ $210.00-23.88%
5/29/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Saket Kalia
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$285.00 ➝ $300.00+7.46%
5/29/2025Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Ryan MacDonald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$270.00 ➝ $300.00+27.46%
3/20/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Anne Samuel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$218.00 ➝ $249.00+5.30%
3/6/2025Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Verkhovski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetSector Perform ➝ Sector Perform$240.00 ➝ $245.00+3.61%
3/6/2025Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Garro
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$280.00 ➝ $280.00+19.63%
3/6/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Joe Vruwink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$283.00 ➝ $285.00+29.36%
1/23/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Gabriela Borges
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Sell$261.00 ➝ $200.00-12.68%
12/6/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetIn-Line ➝ In-Line$220.00 ➝ $245.00-4.09%
12/6/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$280.00 ➝ $290.00+13.44%
12/6/2024Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$275.00 ➝ $285.00+12.20%
12/6/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$210.00 ➝ $270.00+16.55%
10/8/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Degasperi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$286.00+41.70%
10/1/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$233.00 ➝ $249.00+20.00%
8/29/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$180.00 ➝ $192.00-11.20%
7/9/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Larsen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$240.00+31.21%
3/4/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$225.00 ➝ $270.00+21.62%
2/22/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$225.00+2.46%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 07:02 AM ET.


Should I Buy Veeva Systems Stock? VEEV Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, July 10, 2025. Please send any questions or comments about these Veeva Systems pros and cons to contact@marketbeat.com.

Veeva Systems
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Veeva Systems Inc.:

  • The current stock price is around $284.50, reflecting a stable market position and potential for growth.
  • Veeva Systems Inc. reported a significant increase in revenue, with a year-over-year growth of 16.7%, indicating strong demand for its cloud-based software solutions in the life sciences sector.
  • The company has a solid earnings performance, with earnings per share (EPS) of $1.97, surpassing analysts' expectations, which suggests effective management and operational efficiency.
  • Institutional investors hold a substantial 88.20% of the stock, which often indicates confidence in the company's long-term prospects and stability.
  • Veeva Systems Inc. has a healthy return on equity of 13.96%, demonstrating its ability to generate profit from shareholders' equity, a positive sign for potential investors.

Veeva Systems
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Veeva Systems Inc. for these reasons:

  • Insider selling has been observed, with recent transactions showing a 4.43% decrease in ownership by insiders, which may raise concerns about their confidence in the company's future performance.
  • The stock has experienced fluctuations, with a one-year high of $291.69 and a low of $177.41, indicating potential volatility that could affect investment stability.
  • The price-to-earnings (P/E) ratio stands at 60.27, which is relatively high, suggesting that the stock may be overvalued compared to its earnings, potentially limiting future price appreciation.
  • Recent insider sales totaling 1,858 shares valued at $453,734 could signal a lack of confidence among company executives regarding future growth prospects.
  • Despite strong revenue growth, the competitive landscape in the cloud-based software market for life sciences is intense, which could impact Veeva Systems Inc.'s market share and profitability.

VEEV Forecast - Frequently Asked Questions

According to the research reports of 24 Wall Street equities research analysts, the average twelve-month stock price forecast for Veeva Systems is $274.17, with a high forecast of $329.00 and a low forecast of $192.00.

24 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Veeva Systems in the last twelve months. There are currently 2 sell ratings, 8 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" VEEV shares.

According to analysts, Veeva Systems's stock has a predicted downside of -2.79% based on their 12-month stock forecasts.

Analysts like Veeva Systems less than other "medical" companies. The consensus rating score for Veeva Systems is 2.50 while the average consensus rating score for "medical" companies is 2.82. Learn more on how VEEV compares to other companies.


This page (NYSE:VEEV) was last updated on 7/21/2025 by MarketBeat.com Staff
From Our Partners